Sam Murphy - Chief Executive Officer @ Shenzhen Salubris Pharmaceuticals

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	GO Therapeutics	Shenzhen Salubris Pharmaceuticals	—	Funding Round - GO Therapeutics	obfuscated obfuscation

Number of Current Jobs

is the

Chief Executive Officer

Number of Current Board & Advisor Roles

is the

Board Member

Hub Name	CB Rank (Hub)
Guangdong Investors	47,994
Guangdong Public Companies With More Than $10M in Revenue	23,776
Shenzhen Public Companies With More Than 100 Employees	41,576
Guangdong Companies With More Than 1000 Employees	22,481
China Biotechnology Companies	22,075
China Public Companies With More Than 500 Employees	8,725
Companies that Went Public in 2009	32,415
China Companies With More Than $50M in Revenue	7,011
Shenzhen Public Companies With More Than $1M in Revenue	47,170
Guangdong Public Companies With More Than $500 in Revenue	18,115

There is no recent news or activity for this profile.